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E-mail address: takotago@asahikawa-med.ac.jp (TWe examined the change of protein tyrosine kinases (PTKs) expression levels in colonic epithelial
cells isolated from mice in which colitis was induced by oxazolone administration, using the mono-
clonal antibody YK34, which cross-reacts with a wide variety of PTKs. We identiﬁed focal adhesion
kinase (FAK) and found the expression level increased due to the induction of colitis. Furthermore,
we found that there was a positive correlation between FAK expression and the severity of colitis.
Also, FAK expression localized in the colonic epithelium but not in the lamina propria, implying
FAK functions in epithelial cells during colitis formation and/or wound repairing.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction producing antimicrobial peptides and cytokines. The goblet cellsUlcerative colitis and Crohn’s disease are known as inﬂamma-
tory bowel diseases (IBD), which are characterized by the destruc-
tion of the gastrointestinal tract integrity, the excessive production
of cytokines, and subsequent chronic intestinal inﬂammation. The
dysregulation of the mucosal immune system was thought to play
an important role during the initiation of inﬂammation [1]. In Cro-
hn’s disease, T helper cell type 17 (Th17) cytokine interleukin-17
(IL-17), and Th1 cytokines interferon-c and TNF-a increased
[2,3]. In ulcerative colitis, IL-17 and Th2 cytokines usually in-
creased [2–4]. Therefore, the over-activation of immune cells in
intestinal mucosa could cause chronic intestinal inﬂammation.
Although IBD is thought to be related to genetic alterations [5]
and environmental factors [6,7], their etiology and pathologic
mechanisms remain largely unclear.
In the mucosal immune system, the intestinal epithelium has
important functions: as a physical barrier separating luminal
bacteria and immune cells, and as an immunological barrierchemical Societies. Published by E
PTK, protein tyrosine kinase;
. Taniguchi).secrete a layer of mucus that protect the intestinal epithelial cells
from bacteria [8]. Disruption of epithelial integrity by dysregula-
tion of the NF-jB pathway causes spontaneous chronic inﬂamma-
tion because of translocation of bacteria into mucosa [9].
Antimicrobial peptide expression by epithelial cells controls the
microﬂora homeostasis [10,11]. Thus, the reduction of its expres-
sion is thought to be one of the causes of IBD [12]. It is also known
that Toll-like receptors (TLRs), which are activated by intestinal
bacteria and play a major role in the pathogenesis of IBD, are up-
or down-regulated in intestinal epithelial cells [13,14].
It has been believed that protein tyrosine kinases (PTKs) have
critical roles for many cellular functions including immune
response, ulcer formation and wound healing in the intestinal epi-
thelium. In a previous study, Sugiyama et al. produced amonoclonal
antibody, YK34, which cross-reacted with a wide variety of PTKs
[15]. They used antigenic peptides corresponding to a highly con-
served region among various PTKs to produce YK34. In addition,
they detected the change of the PTK expression during differentia-
tion of a leukemia HL60 cell by Western blot using YK34.
We hypothesized that the PTKs expression changed with the dys-
regulation of intestinal epithelial functions caused by inﬂammation.
We therefore induced chemical colitis in mice colons by intrarectallsevier B.V. All rights reserved.
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reactive proteins with YK34 in colonic epithelial cell lysate by two-
dimensional gel electrophoresis (2D-GE) andWestern blot. A database
search using a determined pI value and themolecularweight of immu-
no-reactive spots identiﬁed focal adhesion kinase (FAK) as one of the
PTKs in which the expression level was correlated with the severity
of colitis. We also found that FAK was localized in epithelial cells
regardless of the colitis induction. Our results suggest that FAK is in-
volved in colitis formation and/or colonic epithelial inﬂammation.
2. Materials and methods
2.1. Materials
4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone)
was purchased from Sigma Chemical (St. Louis, MO, USA). Oxazo-
lone was dissolved in 50% ethanol to obtain a 1% (w/v) solution.
YK34 was raised against a highly conserved region (subdomain
VIB) of PTKs [15]. Anti-FAK and -Fer antibodies were purchased
from Abcam (Cambridge, UK). Anti-Syk and -b-actin antibodies
were purchased from Cell Signaling Technology (Danvers, MA,
USA). Horseradish peroxidase-conjugated goat anti-rabbit anti-
body was purchased from Pierce (Rockford, IL, USA).
2.2. Induction of oxazolone colitis
We induced colitis in Male BALB/c mice (weighing 20–25 g,
which were bred in the Animal Care Facility of Asahikawa Medical
University) by intrarectal administration of 100 ll of oxazolone
solution via catheter delivered 4 cm into the colon [16]. Twenty-
four hours after the administration, all the colonic tissues were
dissected and used for further experiments. The degree of inﬂam-
mation was assessed by macroscopic observation as described pre-
viously [17] using the following criteria: 0 – no inﬂammation; 1 –
swelling or redness; 2 – swelling and redness; 3 – one or two ul-
cers; 4 – more than two ulcers or one large ulcer; 5 – mild necrosis;
6 – severe necrosis. All animal procedures were approved by the
Animal Care Committees of Asahikawa Medical University.
2.3. Preparation of colonic epithelial cells and its lysate
We prepared colonic epithelial cells as described [18], in which
the purity of the colonic epithelial cell preparation has been shown
to be approximately 90% [19]. Brieﬂy, the dissected colon was
opened by cutting longitudinally and gently rinsed with ice-cold
phosphate-buffered saline (PBS). Then the colon was cut into
pieces of about 5 mm  5 mm and transferred into a 2.0-ml micro-
tube containing 1.5 ml of PBS. The tube was vortexed for 5 min at
room temperature. After removal of the supernatant, 1 ml of PBS
containing 20 mM EDTA was added into the tube. After vortexing
for 10 min at room temperature, the cell suspension was collected
by centrifugation. This step was repeated 6–8 times. Next, the cells
were suspended in 33% Percoll and centrifuged for 20 min at
400g. After centrifugation, the cells on the top of the 33% Percoll
were collected and used as epithelial cells. Then, the cells were sus-
pended in ﬁve volumes of lysis buffer containing 0.5 M NaCl,
0.2 mM EDTA, 1.5 mM MgCl2, 1 mM DTT, 1 mM PMSF and 20 mM
Tris–HCl, pH 7.5 and lysed by passing through a syringe equipped
22-gauge needle repeatedly. After centrifugation at 12 000g for
20 min at 4 C, the lysate was used for the following experiments.
2.4. Two-dimensional gel electrophoresis
Cell lysates were desalted by trichloroacetic acid precipitation
and the precipitates were dissolved in a sample buffer containing7 M urea, 2 M thiourea, 5 mM Tris–HCl, 0.5% Nonidet P-40 and
5 mM DTT. Isoelectric focusing (IEF) was carried out using agarose
IEF gels (AgarGEL, pH 3–8, ATTO, Tokyo, Japan) in the ﬁrst dimen-
sion and 7.5% polyacrylamide slab gels in the second dimension
according the manufacturer’s guidelines.
2.5. Western blot
Proteins that were separated by gel electrophoresis were trans-
ferred to a Immobilon-P PVDF membrane (Millipore, Billerica, MA,
USA). The membrane was blocked with Tris-buffered saline con-
taining 0.05% Tween 20 (TBST) and 2% ECL Advance Blocking Re-
agent (GE Healthcare UK Ltd., Buckinghamshire, England). After
incubation with the appropriate primary antibody, bound antibody
was detected by using peroxidase-conjugated secondary antibody
and ECL Advance Western Blotting Detection Kit (GE Healthcare).
2.6. Immunohistochemistry
Colonic tissues dissected from mice were ﬁxed with 20% buf-
fered formalin and embedded in parafﬁn, and cut into tissue sec-
tions. After deparafﬁnization, each section was incubated with
1:100 dilution of anti-FAK antibody for 1 h at room temperature
and then washed three times with PBS. Bound primary antibody
was detected by using anti-rabbit antibody and diaminobenzidine
staining.
2.7. Analysis of data
The level of FAK protein expression was measured by densito-
metric measurement of the immuno-reactive signal with anti-
FAK antibody of the Western blots using ImageJ software. FAK
expression levels were normalized based on b-actin expression
levels in same blots.
Results are expressed as the means ± S.E.M. of n experiments.
Statistical signiﬁcance was evaluated using Student’s t-test.
P < 0.05 was considered statistically signiﬁcant. The correlation be-
tween the clinical score and FAK expression level was evaluated by
using Pearson product-moment correlation coefﬁcient.
3. Results
3.1. Induction of colitis by the administration of oxazolone
We employed the oxazolone-induced colitis model that was ac-
cepted as a T helper-2 type model [20,21] similar to human ulcer-
ative colitis. Since we found that the mortality of the oxazolone-
administered mice by the end of day 2 was approximately 50%,
we examined the severity of colitis at 24 h posttreatment. At this
time point, some oxazolone-administered mice showed soft stool,
rectal bleeding and fecal staining around the anus. Macroscopic
examination revealed that inﬂammation had occurred in the distal
colon. However, the severity varied widely; about 30% of the oxa-
zolone-administered mice showed no colitis, redness or swelling of
the bowel wall (clinical score 0 and 1), whereas 40% exhibited mild
to moderate inﬂammation (clinical score 2–4) and the other 30%
displayed large ulcers accompanied with necrosis (clinical score
5 and 6).
3.2. Detection of immuno-reactive proteins with YK34 antibody in
colonic epithelial cell lysate
In order to investigate the change of the PTK expression level,
we carried out 2D-GE and Western blot analysis using the mono-
clonal antibody YK34. Twenty-four hours after the administration
Fig. 2. Changes of the protein expression levels of FAK in epithelial cell lysates. (A)
Representative results of Western blot. Lysates that were prepared from the colonic
epithelial cells of control mice (lanes marked as ) or oxazolone-administered mice
(lanes marked as +) were probed with anti-FAK, -Syk and -Fer antibodies inWestern
blot. The b-actin was also detected as a loading control. (B) Quantiﬁcation of FAK
expression level. Optical density of each band was measured by densitometry. The
expression levels of FAK were then normalized by actin and calculated as a relative
expression level. Each column represents the mean ± S.E.M. of 5 for control- or 11
for oxazolone-administered mice.
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lonic tissue and analyzed by Western blot. As shown in Fig. 1, more
than 10 immuno-reactive spots were detected. Among them, we
found that the intensity of the spot, of which the molecular mass
was 120 kDa and pI value was 6.3, was signiﬁcantly and reproduc-
ibly increased by the administration of oxazolone (Fig. 1, arrow-
heads). On the basis of these values, we searched the UniProtKB/
Swiss-Prot database using the TagIdent program [22] with the fol-
lowing: tyrosine-protein kinases ofMus musculus with a molecular
mass 120 000 ± 12 000 Da and pI value between 6.0 and 6.5. Sev-
eral PTKs including FAK 1 were suggested by the search.
3.3. Oxazolone administration enhances FAK expression in epithelial
cells
Previous studies showed that FAK contributes to wound heal-
ing in gastric injuries [23,24] and FAK expression increased in
epithelial cells near human gastric and colonic ulcers [25]. We
thus examined the protein expression level of FAK in the colon
epithelium. Lysates were prepared from colonic epithelial cells
in mice and were subjected to Western blot using anti-FAK anti-
body. As shown in Fig. 2A, the expression level of FAK after oxa-
zolone administration was signiﬁcantly higher in all lysates
prepared from inﬂamed colonic tissues compared with those
from control tissues. In contrast, other PTKs such as Syk and
Fer did not show any change of their expression levels. Densito-
metric analysis revealed that FAK expression in oxazolone-
administered mice increased to 168 ± 15.5% compared with
ethanol-administered mice (P = 0.011, Fig. 2B).
3.4. FAK expression level correlates with severity of oxazolone-induced
colitis
Using Western blot analysis, we found the variance in the
expression level of FAK in inﬂamed colonic epithelial cell lysates.
In order to examine the correlation between the severity of colitis
and FAK expression level, we assessed the degree of inﬂammation
of each oxazolone-administered mouse colon. The estimated clini-
cal score was plotted as a function of the relative expression level
of FAK (Fig. 3). The correlation between the clinical score and FAK
expression was modest (r = 0.681).
3.5. FAK expression is localized in colonic epithelium but not lamina
propria
We examined the localization of FAK in colonic tissues of con-
trol and oxazolone-administered mice by a immunohistochemical
technique. In both tissues, we observed FAK immunoreactivity inFig. 1. Immuno-reactive proteins with YK34 in epithelial cell lysates. The epithelial
cell lysate that was prepared from the control (left panel) or oxazolone-adminis-
tered (right panel) mouse was separated by 2D-GE and transferred onto a PVDF
membrane. The membrane was incubated with YK34 and the bound antibody was
detected by ECL. Spot intensity that changed between the two panels is indicated by
arrowhead.
Fig. 3. Correlation of clinical scores with FAK expression level. Entire colons were
dissected from 16 oxazolone-administered mice and the degree of inﬂammation
was assessed. Also, the relative expression level of FAK in the epithelial cell lysate
was measured by Western blot.the epithelium, but not lamina propria (Fig. 4). Remarkably, FAK
was not detected in the inﬂammatory inﬁltrate in the oxazolone-
administered tissue. Furthermore, we found signiﬁcantly strong
immunoreactivity in scattered epithelial cells located in destroyed
epithelium (Fig. 4E, arrowheads).
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In the present study, we found that protein expression of FAK in
the colonic epithelial cell increased with the administration of oxa-
zolone to mice, which was known to induce an acute and fulmi-
nated colitis. Although IBD usually has a slow development and
chronic course, the oxazolone-induced colitis was characterized
as a model for human ulcerative colitis, based on a rapidly develop-
ing Th2-mediated colitis formation [16,20,26].
The etiology of IBD is largely unknown, however, it has been
shown that PTK activity in inﬂamed colonic mucosa was signiﬁ-
cantly higher than normal mucosa [27]. Furthermore, it has been
reported that colonic gene and/or protein expression levels of PTKs,
such as c-MET [28], EGFR [29], ErbB [30], Tie-2 [31], IGF1R [32],
and RON [33] were changed during inﬂammation. To ﬁnd PTK(s)
involved in colitis formation, we used the monoclonal antibody,Fig. 4. Immunohistochemical examination of the colonic sections. The colon tissues from
as described in Section 2 with 40 magniﬁcation (A and B), 100 (C and D) and 200 (YK34, which was raised against a highly conserved domain among
a variety of PTKs [15]. We found that more than 10 immuno-reac-
tive spots were detected. Although the intensity of most of the
spots did not change regardless of the administration of oxazolone,
we identiﬁed one spot in which intensity increased in the induc-
tion of colitis in a reproducible manner (Fig. 1). Based on the infor-
mation of the spots in 2D-GE and Western blot, we identiﬁed FAK
as a candidate that may have some relevance in the induction of
colitis.
FAK is well known as one of the non-receptor tyrosine kinases
and has an important role in signal transduction pathways of inte-
grin-mediated cell adhesion. FAK interacts with not only integrins
but also various adaptor proteins and growth factor receptors, such
as EGF, PDGF and HGF receptors at focal adhesion. The kinase activ-
ity of FAK can be regulated by these growth factors and its activa-
tion causes the interaction and/or tyrosine phosphorylation ofcontrol mice (A and C) and oxazolone-administered mice (B, D and E) were analyzed
E).
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reorganization of focal adhesion [34,35].
Our results clearly showed the increase of FAK expression in the
colonic epithelial cells of the oxazolone-administered mice. The
expression of FAK is regulated by several growth factors and cyto-
kines. The mechanism of this increase is still unknown. However,
several possible mechanisms could be supposed.
One mechanism is that cytokines or growth factors secreted
from immune cells may activate the transcription of the FAK
gene in epithelial cells. In the oxazolone colitis mouse model,
the production of Th2-cytokines and growth factors, such as
IL-4, IL-13 and TGFb, is highly enhanced. It is known that these
cytokines enhance the transcription of various genes via the JAK/
STAT pathway. In addition, Walsh et al. reported that TGFb
enhanced FAK expression via Smad and p38 mitogen-activated
protein kinase (MAPK) dependent pathways in human gastric
and colonic ulcers [25]. Therefore, FAK expression in epithelial
cells of oxazolone-administered mice may be enhanced by the
same pathway.
Another mechanism is that the inert immune response of colo-
nic epithelial cells may cause the enhancement of FAK protein
expression. Colonic epithelial cells have important molecules for
the inert immune system, Toll-like receptors and NOD molecules.
The activation of these proteins by pathogenic bacterial compo-
nents causes activation of NF-jB pathways. Golubovskaya et al. re-
ported that the 50-ﬂanking region of FAK contains several potential
transcription factor binding sites, and transcriptional activity of
FAK was regulated by NF-jB [36]. Furthermore, both MAPK and
the NF-jB pathways were also strongly activated in IBD [37]. These
arguments are consistent with our results.
A third mechanism is related to the correlation between FAK
expression level and severity of colitis. It has been suggested that
levels of FAK protein expression and/or activation have been corre-
lated to intestinal epithelial motility [38,39]. In gastric ulcers, FAK
plays an important role in wound healing [23,24].
TNF-a, which is well known as a proinﬂammatory cytokine and
plays a key role in the pathogenesis of IBD, has been shown to acti-
vate FAK by binding to the receptors, TNFR1 and TNFR2 [40,41],
and to induce an increase in FAK transcription [36]. Because we
found that FAK immunoreactivity in inﬂamed colonic tissues was
detected only in the epithelium, our results implied the functions
of FAK for ulcer formation or wound healing in an inﬂamed colon
and for pathogenesis in ulcerative colitis.
Lastly, the increase in FAK expression could be a cause, and at
the same time, be a consequence of colitis. It still remains to be
clariﬁed when and/or in which step FAK functions in this colitis
model. Also, an alteration of FAK expression should be examined
in other colitis models, which have a slower onset and chronic time
course, such as a drug-induced model, IL-2 or IL-10 knock out mice,
IL-7 transgenic mice [42], in order to uncover the relevance of FAK
in colitis formation and in the pathogenesis of IBD.
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